The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Betnesol 0.1% w/v Eye, Ear and Nasal Drops, solution



RPH Pharmaceuticals ABPA1638/001/001

Main Information

Trade NameBetnesol 0.1% w/v Eye, Ear and Nasal Drops, solution
Active SubstancesBETAMETHASONE SODIUM PHOSPHATE
Dosage FormEar/eye/nasal drops, solution
Licence HolderRPH Pharmaceuticals AB
Licence NumberPA1638/001/001

Group Information

ATC CodeS02BA Corticosteroids
S02BA07 betamethasone

Status

License statusAuthorised
Licence Issued01/04/1978
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceNone
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back